Global Anti-migraine Drugs Market $15.6 Billion by 2029
4.9 (407) · € 31.99 · En Stock
The global market for acute and preventive anti-migraine drugs estimated reach $15.6 billion by 2029, expanding at a CAGR of 9.9% over the forecast period, driven by enormous patient population, high cost of innovative new drugs, and strong pipeline of novel therapies.
Migraine Drugs Market Analysis - US,Canada,Germany,China,Japan
Migraine market continues exponential growth - IQVIA
Acute Migraine Drugs Market Size, Share, Growth & Forecast
Acute Migraine Treatment Market Size, Growth Analyssis 2031
EX-13
Migraine market continues exponential growth - IQVIA
Anti-Migraine Drugs Market Research Report Unlocks Analysis on the
Migraine Drugs Market: Key Findings, Executive Summary
Lilly's Emgality fails to beat Pfizer option in migraine prevention
)
